EUVIMEDEUVIMED entdecken
Crossref

Re-discovery of MS-347a as a fungicide candidate through a new drug discovery platform with a multidrug-sensitive Saccharomyces cerevisiae screening system and the introduction of a global secondary metabolism regulator, laeA gene

Sota Honma, Aoi Kimishima, Atsushi Kimishima, Masako Honsho, Hiroki Kojima, Toshiyuki Tokiwa, Atsuka Nishitomi, Satoshi Kato, Naozumi Kondo, Yasuko Araki, Tadashi Takahashi, Takumi Chinen und 4 weitere

Bioscience, Biotechnology, and Biochemistry · 2024

DOI: 10.1093/bbb/zbae050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience, Biotechnology, and Biochemistry, 2024. Verfasst von Sota Honma und 15 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Saccharomyces cerevisiae, Drug Discovery. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: BINDS, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We found that the culture broth of fungi showed anti-fungal activity against multidrug-sensitive budding yeast. However, we could not identify the anti-fungal compound due to the small quantity. Therefore, we attempted to increase the productivity of the target compound by the introduction of a global secondary metabolism regulator, laeA to the strain, which led to the successful isolation of 10-folds greater amount of MS-347a (1) than Aspergillus sp. FKI-5362. Compound 1 was not effective against Candida albicans and the detailed anti-fungal activity of 1 remains unverified. After our anti-fungal activity screening, 1 was found to inhibit the growth of broad plant pathogenic fungal species belonging to the Ascomycota. It is noteworthy that 1 showed little insecticidal activity against silkworms, suggesting its selective biological activity against plant pathogenic fungi. Our study implies that the combination strategy of multidrug-sensitive yeast and the introduction of laeA is useful for new anti-fungal drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Saccharomyces cerevisiaeDrug DiscoveryCandida albicansSecondary MetabolismFungicides, IndustrialAntifungal AgentsMicrobial Sensitivity TestsAscomycotaAspergillusDrug Evaluation, PreclinicalSaccharomyces cerevisiae ProteinsFungal Proteins

Stichwörter der Autor:innen

Aspergillus spLaeAfungicide candidatesmultidrug-sensitive budding yeastnatural products

Substanzen

Fungicides, IndustrialAntifungal AgentsSaccharomyces cerevisiae ProteinsFungal Proteins

Autor:innen und Institutionen

  • Graduate School of Infection Control Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, Japan.
  • Ōmura Satoshi Memorial Institute, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, Japan.
  • Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamada-oka, Suita, Osaka, Japan.
  • Research and Development Division, Kikkoman Corporation, 338 Noda, Noda-shii, Chiba, Japan.
  • Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.
  • Graduate School of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.

ORCID-Profile: Takeo Usui, Yukihiro Asami

Förderung

  • BINDS
  • Japan Agency for Medical Research and Development

Zitieren

APA

Honma, S., Kimishima, A., Kimishima, A., Honsho, M., Kojima, H., Tokiwa, T., Nishitomi, A., Kato, S., Kondo, N., Araki, Y., Takahashi, T., Chinen, T., Usui, T., Fuji, S. I., Ito, K., & Asami, Y. (2024). Re-discovery of MS-347a as a fungicide candidate through a new drug discovery platform with a multidrug-sensitive Saccharomyces cerevisiae screening system and the introduction of a global secondary metabolism regulator, laeA gene. Bioscience, Biotechnology, and Biochemistry. https://doi.org/10.1093/bbb/zbae050

Vancouver

Honma S, Kimishima A, Kimishima A, Honsho M, Kojima H, Tokiwa T, et al. Re-discovery of MS-347a as a fungicide candidate through a new drug discovery platform with a multidrug-sensitive Saccharomyces cerevisiae screening system and the introduction of a global secondary metabolism regulator, laeA gene. Bioscience, Biotechnology, and Biochemistry. 2024. doi:10.1093/bbb/zbae050

BibTeX
@article{Honma2024,
  author = {Honma, Sota and Kimishima, Aoi and Kimishima, Atsushi and Honsho, Masako and Kojima, Hiroki and Tokiwa, Toshiyuki and Nishitomi, Atsuka and Kato, Satoshi and Kondo, Naozumi and Araki, Yasuko and Takahashi, Tadashi and Chinen, Takumi and Usui, Takeo and Fuji, Shin-Ichi and Ito, Kotaro and Asami, Yukihiro},
  title = {Re-discovery of MS-347a as a fungicide candidate through a new drug discovery platform with a multidrug-sensitive Saccharomyces cerevisiae screening system and the introduction of a global secondary metabolism regulator, laeA gene},
  journal = {Bioscience, Biotechnology, and Biochemistry},
  year = {2024},
  doi = {10.1093/bbb/zbae050}
}
Kostenlos starten →